Polymedco, Inc.: What’s Next in ED Chest Pain Care: Integrating Point-of-Care High Sensitivity Troponin into Your Workflow

Sunday, September 29
2:30 – 3:15 pm
Location: Exhibit Hall, Expert Theater 1

Speaker

Simon A. Mahler MD, MS, FACEP, Professor & Vice Chair of Research, Department of Emergency Medicine, Wake Forest School of Medicine

Theater Information

Each year, 7-9 million patients with symptoms of possible Acute coronary syndrome (ACS) present to U.S. emergency departments (EDs). Many of these patients are hospitalized for in-depth evaluations, yet <10% are ultimately diagnosed with ACS. Correctly identifying the few patients with ACS is challenging and high-stakes for ED providers. Missing ACS leads to significant morbidity and mortality, but over-testing for possible ACS is associated with lengthy hospital-based evaluations and prolonged ED stays, which exacerbates ED and hospital crowding and costs $ billions annually. New care paradigms for ED ACS evaluations are needed to safely identify patients with ACS, while maximizing ED discharges and through-put. Point-of-care (POC) high sensitivity cardiac troponin assays (hs-cTn) assays are a recent breakthrough that have the potential to greatly accelerate ED evaluations for ACS and safely enhance throughput. Health systems must consider whether to implement POC hs-cTn technology and how best to implement them to improve the efficiency and quality of care.

Supported by Polymedco, Inc.